Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-25 @ 2:08 PM
NCT ID:
NCT04118166
Group ID:
EG000
Title:
Ipilimumab/Nivolumab + Cryotherapy
Description:
1 mg/kg with nivolumab 3 mg/kg every 3 weeks x 4 doses. (One cycle of treatment is 3 weeks). Cryotherapy (cryoablation) will be performed between investigational agent treatment Cycles 1 and 2
Ipilimumab: Ipilimumab 1 mg/kg, injection
Cryoablation: Cryoablation of the tumors occur between investigational agent treatment Cycles 1 and 2, and will be performed according to standard procedures
Nivolumab: Nivolumab 3 mg/kg, injection
Deaths Number Affected:
15
Deaths Number At Risk:
None
Serious Number Affected:
30
Serious Number At Risk:
30
Other Number Affected:
30
Other Number At Risk:
30
Study:
NCT04118166
Results Section:
NCT04118166
Adverse Events Module:
NCT04118166